Published in Circ Cardiovasc Imaging on January 24, 2013
Micro-CT of rodents: state-of-the-art and future perspectives. Phys Med (2014) 0.90
Spectral diffusion: an algorithm for robust material decomposition of spectral CT data. Phys Med Biol (2014) 0.81
Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features. J Nucl Med (2015) 0.80
A neural network-based method for spectral distortion correction in photon counting x-ray CT. Phys Med Biol (2016) 0.79
Noninvasive detection of macrophages in atheroma using a radiocontrast-loaded phosphatidylserine-containing liposomal contrast agent for computed tomography. Mol Imaging Biol (2015) 0.78
Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies. Adv Drug Deliv Rev (2016) 0.77
Ultra High-Resolution In vivo Computed Tomography Imaging of Mouse Cerebrovasculature Using a Long Circulating Blood Pool Contrast Agent. Sci Rep (2015) 0.77
Optimizing dual energy cone beam CT protocols for preclinical imaging and radiation research. Br J Radiol (2016) 0.77
Spectrotemporal CT data acquisition and reconstruction at low dose. Med Phys (2015) 0.75
In vivo small animal micro-CT using nanoparticle contrast agents. Front Pharmacol (2015) 0.75
Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models. Int J Mol Sci (2016) 0.75
Hybrid spectral CT reconstruction. PLoS One (2017) 0.75
Inflammation in atherosclerosis. Nature (2002) 28.92
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb (1994) 8.54
Pathology of the vulnerable plaque. J Am Coll Cardiol (2006) 7.79
Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation (2007) 3.85
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med (2007) 3.40
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater (2006) 2.84
Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol (2011) 2.83
Micro-CT with respiratory and cardiac gating. Med Phys (2004) 2.83
In vivo imaging of proteolytic activity in atherosclerosis. Circulation (2002) 2.62
Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation (2001) 2.55
Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology (2010) 2.43
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol (1997) 2.39
A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol (2006) 2.21
18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging (2009) 2.17
Adipose tissue macrophages. Immunol Lett (2007) 2.02
Mouse models of experimental atherosclerosis. J Physiol Pharmacol (2004) 1.68
In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation (2004) 1.53
Macrophage polarization in health and disease. ScientificWorldJournal (2011) 1.46
Pathology of the unstable plaque. Prog Cardiovasc Dis (2002) 1.41
Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. J Nucl Med (2009) 1.31
Geometric calibration for a dual tube/detector micro-CT system. Med Phys (2008) 1.27
Dual-source dual-energy CT with additional tin filtration: Dose and image quality evaluation in phantoms and in vivo. AJR Am J Roentgenol (2010) 1.20
High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent. AJNR Am J Neuroradiol (2007) 1.15
Atherosclerosis and thrombosis: insights from large animal models. J Biomed Biotechnol (2011) 1.15
The pathogenesis of atherosclerosis. Can Med Assoc J (1951) 1.14
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials. Semin Oncol (2004) 1.10
Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol (2011) 1.10
Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle. J Am Chem Soc (2009) 1.08
The interaction of liposomes with the complement system. Crit Rev Ther Drug Carrier Syst (1998) 1.07
Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med (2008) 1.05
T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents--effect of liposome size and internal gadolinium concentration. Acad Radiol (2008) 1.04
Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation (2003) 0.99
Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J (2007) 0.96
99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med (2005) 0.92
Denoising of 4D Cardiac Micro-CT Data Using Median-Centric Bilateral Filtration. Proc SPIE Int Soc Opt Eng (2012) 0.90
Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. Cardiovasc Pathol (2005) 0.90
Multislice CT angiography assessment of left coronary artery: correlation between bifurcation angle and dimensions and development of coronary artery disease. Eur J Radiol (2011) 0.90
Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent. Int J Nanomedicine (2009) 0.87
Pharmacokinetic analysis of the uptake of liposomes by macrophages and foam cells in vitro and their distribution to atherosclerotic lesions in mice. Drug Metab Pharmacokinet (2006) 0.81
Imaging of pulmonary embolism and t-PA therapy effects using MDCT and liposomal iohexol blood pool agent: preliminary results in a rabbit model. Acad Radiol (2007) 0.79
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (2009) 10.52
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation (2003) 5.34
Sparseness prior based iterative image reconstruction for retrospectively gated cardiac micro-CT. Med Phys (2007) 4.64
A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med (2009) 4.46
Development of a 4-D digital mouse phantom for molecular imaging research. Mol Imaging Biol (2004) 4.15
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation (2005) 3.83
Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol (2007) 3.48
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation (2003) 3.45
Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest (2006) 3.22
MRI of the lungs using hyperpolarized noble gases. Magn Reson Med (2002) 2.80
Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol (2004) 2.74
The role of periadventitial fat in atherosclerosis. Arch Pathol Lab Med (2007) 2.59
Digital atlasing and standardization in the mouse brain. PLoS Comput Biol (2011) 2.53
Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet (2009) 2.50
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol (2005) 2.42
Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation (2003) 2.28
Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy. Circ Res (2012) 2.25
4-D micro-CT of the mouse heart. Mol Imaging (2005) 2.25
A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol (2006) 2.21
Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation (2003) 2.11
Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation (2004) 2.05
Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol (2007) 2.04
Imaging alveolar-capillary gas transfer using hyperpolarized 129Xe MRI. Proc Natl Acad Sci U S A (2006) 2.04
High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. Neuroimage (2011) 1.98
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol (2006) 1.96
Vulnerable atherosclerotic plaque: a multifocal disease. Circulation (2003) 1.84
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN). J Cardiovasc Transl Res (2010) 1.84
Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circ Cardiovasc Genet (2010) 1.83
Hippo signaling impedes adult heart regeneration. Development (2013) 1.81
Mechanical ventilation for imaging the small animal lung. ILAR J (2002) 1.81
Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study. Circ Cardiovasc Genet (2009) 1.80
Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann N Y Acad Sci (2010) 1.74
Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation (2003) 1.74
Five common gene variants identify elevated genetic risk for coronary heart disease. Genet Med (2007) 1.72
Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors. Proc Natl Acad Sci U S A (2012) 1.72
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol (2011) 1.71
Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol (2005) 1.67
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation (2003) 1.63
A dual micro-CT system for small animal imaging. Proc SPIE Int Soc Opt Eng (2008) 1.62
High-resolution magnetic resonance histology of the embryonic and neonatal mouse: a 4D atlas and morphologic database. Proc Natl Acad Sci U S A (2008) 1.61
Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation (2004) 1.55
E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1. Circulation (2002) 1.54
Automated segmentation of neuroanatomical structures in multispectral MR microscopy of the mouse brain. Neuroimage (2005) 1.52
Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium. Circ Cardiovasc Genet (2010) 1.52
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. Tex Heart Inst J (2010) 1.52
Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ Res (2007) 1.51
High-resolution imaging of murine myocardial infarction with delayed-enhancement cine micro-CT. Am J Physiol Heart Circ Physiol (2007) 1.51
Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation (2004) 1.51
Markers of autophagy are downregulated in failing human heart after mechanical unloading. Circulation (2009) 1.48
Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther (2010) 1.47
Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study. Eur J Clin Invest (2010) 1.47
ACCF/AHA consensus conference report on professionalism and ethics. Circulation (2004) 1.47
Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res (2011) 1.47
Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation (2004) 1.46
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). Circ Cardiovasc Qual Outcomes (2009) 1.46
Enhanced T2 contrast for MR histology of the mouse brain. Magn Reson Med (2006) 1.41
3D fiber tractography with susceptibility tensor imaging. Neuroimage (2011) 1.39
Preserved homograft function 32 years after surgery in a young patient. J Thorac Cardiovasc Surg (2010) 1.38
Adult stem cell therapy in perspective. Circulation (2003) 1.38
Intracardiac septation requires hedgehog-dependent cellular contributions from outside the heart. Development (2008) 1.37
Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv (2007) 1.36
A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J (2011) 1.35
Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res (2005) 1.34
Staining methods for magnetic resonance microscopy of the rat fetus. J Magn Reson Imaging (2007) 1.32
Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms. Circulation (2009) 1.30
The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy. Circ Res (2013) 1.30
Ventilation-synchronous magnetic resonance microscopy of pulmonary structure and ventilation in mice. Magn Reson Med (2005) 1.29
Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res (2009) 1.28
Geometric calibration for a dual tube/detector micro-CT system. Med Phys (2008) 1.27
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release (2003) 1.27
Neuroanatomical phenotypes in the reeler mouse. Neuroimage (2006) 1.26
Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res (2010) 1.26
Effects of breathing and cardiac motion on spatial resolution in the microscopic imaging of rodents. Magn Reson Med (2005) 1.24
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol (2009) 1.22
The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med (2008) 1.21
Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model. J Control Release (2010) 1.19
Microscopic diffusion tensor imaging of the mouse brain. Neuroimage (2009) 1.19
Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. Am Heart J (2012) 1.19
Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation (2005) 1.18
Ethanol-induced face-brain dysmorphology patterns are correlative and exposure-stage dependent. PLoS One (2012) 1.17
Rapid production of specialized animal handling devices using computer-aided design and solid freeform fabrication. J Magn Reson Imaging (2009) 1.17
Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med (2006) 1.17
3He MRI in mouse models of asthma. Magn Reson Med (2007) 1.16
Automated segmentation of the actively stained mouse brain using multi-spectral MR microscopy. Neuroimage (2007) 1.16
Measurement of regional lung function in rats using hyperpolarized 3helium dynamic MRI. Magn Reson Med (2003) 1.16